PR94433

EAST RUTHERFORD, N.J., Feb. 8, 2022 /PRNewswire=KYODO JBN/ --

Cambrex, a leading global contract development and manufacturing organization

(CDMO), announced today that it has been recognized by the annual CMO (Contract

Manufacturing Organization) Leadership Awards in the categories of Quality and

Service. This marks the eighth consecutive year Cambrex has been acknowledged

with an award.

"Cambrex is honored to be identified once again by our customers and industry

peers as a leading supplier to the pharmaceutical industry. To be recognized in

the categories of quality and service delivery reflects our technical expertise

and our approach to delivering customized solutions focused on our customers'

needs," said Thomas Loewald, Chief Executive Officer at Cambrex. He added,

"Demand for outsourced pharmaceutical development and manufacturing is growing

steadily. At Cambrex, we are committed to investing in the capacity,

capabilities, and expertise needed to strengthen our position as a leading

global CDMO."

CMO Leadership Awards results are based on primary market research from

Industry Standard Research's Contract Manufacturing Quality Benchmarking annual

online surveys. For the 2022 CMO Leadership Awards, 86 CMOs were evaluated on

23 performance metrics. Research participants were recruited from

biopharmaceutical companies of all sizes and were screened for decision-making

influence and authority when it comes to working with CMOs. Respondents only

evaluated companies with which they had worked on an outsourced project within

the past 18 months. This level of qualification ensures that ratings come from

actual involvement with a business and that companies identified as leaders are

backed by experiential data. CMOs must meet the minimum threshold of customer

survey responses to be eligible for an award.

"Congratulations to all the Life Science Leader and Outsourced Pharma 2022 CMO

Leadership Award winners," announced Louis Garguilo, Chief Editor and

Conference Chair, Outsourced Pharma. "You are the biopharma industry's top

service providers – those who have excelled for your customers through pandemic

hurdles, supply-chain challenges, and advancing demands of new platforms and

technologies."

Cambrex recently celebrated the 40th anniversary of its founding in 1981.

Following 40 years of growth and transformation into a leading global contract

development and manufacturing organization, Cambrex continues its commitment to

leadership in pharmaceutical drug substance manufacturing with over $100

million of investments in progress across its global manufacturing network.

About Cambrex

Cambrex is a leading global contract development and manufacturing organization

(CDMO) that provides drug substance, drug product, and analytical services

across the entire drug lifecycle. With over 40 years of experience and a

growing team of over 2,200 experts servicing global clients from North America

and Europe, Cambrex is a trusted partner in branded and generic markets for API

and finished dosage form development and manufacturing.

Cambrex offers a range of specialized drug substance technologies and

capabilities, including biocatalysis. Continuous flow, controlled substances,

solid-state science, material characterization, and highly potent APIs. In

addition, Cambrex can support conventional dosage forms, including oral solids,

semi-solids, and liquids, and has the expertise to manufacture specialty dosage

forms such as modified-release, fixed-dose combination, pediatric, bi-layer

tablets, stick packs, topicals, controlled substances, sterile, and non-sterile

ointments.

For more information, visit http://www.cambrex.com

About the CMO Leadership Awards

Now in its 11th year, Outsourced Pharma [ https://www.outsourcedpharma.com/ ]

and Life Science Leader's [ https://www.lifescienceleader.com/ ] CMO Leadership

Awards provide readers with accurate and reliable customer feedback to assist

them in choosing a reputable partner for their development and manufacturing

needs. For the 2022 CMO Leadership Awards, Industry Standard Research (ISR)

determined the award recipients through their evaluation of more than 86

contract manufacturers. These CMOs were assessed by 23 performance metrics in

ISR's annual Contract Manufacturing Quality Benchmarking survey.

Logo - https://mma.prnewswire.com/media/1723116/Cambrex_40_Years_Logo.jpg

Source: Cambrex